
Sign up to save your podcasts
Or


In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.
By Janus Henderson Investors4.7
1414 ratings
In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.

522 Listeners

974 Listeners

4,371 Listeners

1,930 Listeners

290 Listeners

663 Listeners

2,116 Listeners

1,299 Listeners

6,060 Listeners

9,956 Listeners

1,560 Listeners

446 Listeners

208 Listeners

76 Listeners

0 Listeners

3 Listeners